Zobrazeno 1 - 10
of 27
pro vyhledávání: '"L C, Petersen"'
Publikováno v:
Blood Coagulation & Fibrinolysis. 5:707-712
High dose aprotinin administered during cardiopulmonary bypass (CPB) has been shown to reduce post-operative bleeding substantially. The exact mechanism of action is still debated. A reduction in fibrinolytic activity by inhibition of plasmin generat
Publikováno v:
Methods of Biochemical Analysis, Volume 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bfb82a465cbed52a30f8b99f839c089
https://doi.org/10.1002/9780470110461.ch2
https://doi.org/10.1002/9780470110461.ch2
Autor:
R H, Myers, L C, Petersen
Publikováno v:
Managed care interface. 14(9)
The intense scrutiny given to the privacy implications of the Gramm-Leach-Bliley Act and the Health Insurance Portability and Accountability Act has led to much confusion regarding which applies to specific entities. The authors attempt to clarify wh
Publikováno v:
Thrombosis and haemostasis. 83(4)
The protease activity is mandatory for intracellular activities induced by coagulation factor VIIa (FVIIa), and in this way it resembles signal transduction induced by thrombin and trypsin caused by specific, proteolytic cleavage of protease activate
Publikováno v:
Blood. 94(5)
Recent studies have shown a discrepancy between the level of tissue factor (TF) expression and the level of TF procoagulant activity on the apical and basolateral surface domains of polarized epithelial cells. The present investigation was performed
Autor:
Laurence A. Harker, Nicolas A.F. Chronos, Andrew B. Kelly, Ulla M. Marzec, Stephen R. Hanson, U. Hedner, I. B. Sundell, L. C. Petersen
Publikováno v:
Circulation. 96(3)
Background To enhance thrombolytic responses without increasing hemorrhagic risks, the antithrombotic effects of recombinant Lys-plasminogen (r-LysPgn), a prothrombolytic plasminogen intermediate, were examined in baboon models of thrombus formation
Autor:
L C, Petersen, E, Persson
Publikováno v:
Haemostasis. 26
Binding of Ca2+ to factor VIIa is required for its binding to phospholipids, tissue factor, and for obtaining full amidolytic activity. This presentation describes various binding studies performed with recombinant factor VIIa and fragments hereof in
Publikováno v:
Haemostasis. 23
Tissue factor pathway inhibitor (TFPI) is released into the circulation after intravenous or subcutaneous injection of heparin or low-molecular-weight heparin (Logiparin) in humans. The plasma concentration of TFPI is increased 2- to 4-fold by a prop
Publikováno v:
Thrombosis and haemostasis. 67(5)
The effect of human neutrophil elastase and cathepsin G on recombinant tissue factor pathway inhibitor (TFPI) was investigated. A weak inhibition by TFPI of both elastase (Ki = 0.4 microM) and cathepsin G (Ki = 0.1 microM) was observed. Neutrophil el
Publikováno v:
Thrombosis and haemostasis. 65(5)
Although it is well established that calcium is an essential cofactor in blood coagulation, recent experimental evidence suggests that zinc may also play an important role in hemostasis. In the present study, we have examined the effect of zinc ions